Top October 2020 FDA Approvals
The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.
The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.
The PA Foundation has established a fellowship to train physician assistants to be mental health first aid course instructors.
Researchers indicate that fears of visiting an emergency department because of the pandemic may be unfounded after concluding that SARS-CoV-2 transmission inside an ED is unlikely.
Nurse practitioners (NPs) executed a 5-step vaccination program for homeless individuals in Miami-Dade County to help reduce the spread of infectious diseases.
Nurses are experiencing depressive symptoms and sleep difficulties because of the COVID-19 pandemic, according to a survey of nearly 10,000 nurses.
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
As part of a 3-phase plan to combat COVID-19 outbreaks in long-term care facilities, UW Medicine has deployed drop teams to conduct rapid testing services.
Excessive stress because of the COVID-19 pandemic can have a detrimental effect on nurses’ mental health; therefore, the APNA has developed a Well-Being Initiative for nurses seeking help for excessive stress.
Remote lectures and socially-distant laboratory evaluations are changing the landscape of physician assistant programs across the country.
The CDC examines trends in the weekly incidence of COVID-19 among school-aged children to inform decisions about reopening schools and preventing community spread of COVID-19.